|
1
|
Sampson VB, Kamara DF and Kolb EA:
Xenograft and genetically engineered mouse model systems of
osteosarcoma and Ewings sarcoma: Tumor models for cancer drug
discovery. Expert Opin Drug Discov. 8:1181–1189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tabatabaei SH, Jahanshahi G and Marvasti F
Dehghan: Diagnostic challenges of low-grade central osteosarcoma of
jaw: A literature review. J Dent (Shiraz). 16:62–67.
2015.PubMed/NCBI
|
|
3
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai
Z: Research progress on the multidrug resistance mechanisms of
osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Y and Teng JS: Increased multi-drug
resistance and reduced apoptosis in osteosarcoma side population
cells are crucial factors for tumor recurrence. Exp Ther Med.
12:81–86. 2016.PubMed/NCBI
|
|
5
|
Dmitrieva OS, Shilovskiy IP, Khaitov MR
and Grivennikov SI: Interleukins 1 and 6 as main mediators of
inflammation and cancer. Biochemistry. 81:80–90. 2016.PubMed/NCBI
|
|
6
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen XW and Zhou SF: Inflammation,
cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Drug
Des Devel Ther. 9:2941–2946. 2015.PubMed/NCBI
|
|
8
|
Jearaphunt M, Noonin C, Jiravanichpaisal
P, Nakamura S, Tassanakajon A, Söderhäll I and Söderhäll K:
Caspase-1-like regulation of the proPO-system and role of ppA and
caspase-1-like cleaved peptides from proPO in innate immunity. PLoS
Pathog. 10:e10040592014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ataide MA, Andrade WA, Zamboni DS, Wang D,
Souza MC, Franklin BS, Elian S, Martins FS, Pereira D, Reed G, et
al: Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation
mediates inflammation and hypersensitivity to bacterial
superinfection. PLoS Pathog. 10:e10038852014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Exline MC, Justiniano S, Hollyfield JL,
Berhe F, Besecker BY, Das S, Wewers MD and Sarkar A: Microvesicular
caspase-1 mediates lymphocyte apoptosis in sepsis. PLoS One.
9:e909682014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miao EA, Rajan JV and Aderem A:
Caspase-1-induced pyroptotic cell death. Immunol Rev. 243:206–214.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu D, Fu S, Cao Z, Bao M, Zhang G, Pan Y,
Liu W and Zhou Q: Unraveling the novel anti-osteosarcoma function
of coptisine and its mechanisms. Toxicol Lett. 226:328–336. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Su K, Hu P, Wang X, Kuang C, Xiang Q, Yang
F, Xiang J, Zhu S, Wei L and Zhang J: Tumor suppressor berberine
binds VASP to inhibit cell migration in basal-like breast cancer.
Oncotarget. Jun 13–2016.doi: 10.18632/oncotarget.9968.
|
|
14
|
Zhang XZ, Wang L, Liu DW, Tang GY and
Zhang HY: Synergistic inhibitory effect of berberine and d-limonene
on human gastric carcinoma cell line MGC803. J Med Food.
17:955–962. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin X, Yan TH, Yan L, Li Q, Wang RL, Hu
ZL, Jiang YY, Sun QY and Cao YB: Design, synthesis, and anticancer
activity of novel berberine derivatives prepared via CuAAC ‘click’
chemistry as potential anticancer agents. Drug Des Devel Ther.
8:1047–1059. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Y, Ma N, Li HX, Tian L, Ba YF and Hao
B: Berberine induces apoptosis and DNA damage in MG-63 human
osteosarcoma cells. Mol Med Rep. 10:1734–1738. 2014.PubMed/NCBI
|
|
17
|
Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F,
Yang Q, Gao G, Gong Y and Shao C: Berberine induces p53-dependent
cell cycle arrest and apoptosis of human osteosarcoma cells by
inflicting DNA damage. Mutat Res. 662:75–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Man SM and Kanneganti TD: Converging roles
of caspases in inflammasome activation, cell death and innate
immunity. Nat Rev Immunol. 16:7–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin Y, Wu W, Zhang W, Zhao Y, Wu Y, Ge G,
Ba Y, Guo Q, Gao T, Chi X, et al: Involvement of EGF receptor
signaling and NLRP12 inflammasome in fine particulate
matter-induced lung inflammation in mice. Environ Toxicol. Jul
5–2016.(Epub ahead of print) doi.org/10.1002/tox.22308. View Article : Google Scholar
|
|
20
|
Heymann D, Ory B, Blanchard F, Heymann MF,
Coipeau P, Charrier C, Couillaud S, Thiery JP, Gouin F and Redini
F: Enhanced tumor regression and tissue repair when zoledronic acid
is combined with ifosfamide in rat osteosarcoma. Bone. 37:74–86.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sansone P and Bromberg J: Environment,
inflammation, and cancer. Curr Opin Genet Dev. 21:80–85. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vakkila J and Lotze MT: Inflammation and
necrosis promote tumour growth. Nat Rev Immunol. 4:641–648. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Persidsky Y, Hill J, Zhang M, Dykstra H,
Winfield M, Reichenbach NL, Potula R, Mukherjee A, Ramirez SH and
Rom S: Dysfunction of brain pericytes in chronic neuroinflammation.
J Cereb Blood Flow Metab. 36:794–807. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cerretti DP, Kozlosky CJ, Mosley B, Nelson
N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T,
Cannizzaro LA, et al: Molecular cloning of the interleukin-1 beta
converting enzyme. Science. 256:97–100. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mariathasan S, Newton K, Monack DM, Vucic
D, French DM, Lee WP, Roose-Girma M, Erickson S and Dixit VM:
Differential activation of the inflammasome by caspase-1 adaptors
ASC and Ipaf. Nature. 430:213–218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scott EN, Gescher AJ, Steward WP and Brown
K: Development of dietary phytochemical chemopreventive agents:
Biomarkers and choice of dose for early clinical trials. Cancer
Prev Res (Phila). 2:525–530. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mantena SK, Sharma SD and Katiyar SK:
Berberine inhibits growth, induces G1 arrest and apoptosis in human
epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin
cascade, disruption of mitochondrial membrane potential and
cleavage of caspase 3 and PARP. Carcinogenesis. 27:2018–2027. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Katiyar SK, Meeran SM, Katiyar N and
Akhtar S: p53 Cooperates berberine-induced growth inhibition and
apoptosis of non-small cell human lung cancer cells in vitro and
tumor xenograft growth in vivo. Mol Carcinog. 48:24–37. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Letasiová S, Jantová S, Miko M, Ovádeková
R and Horváthová M: Effect of berberine on proliferation,
biosynthesis of macromolecules, cell cycle and induction of
intercalation with DNA, dsDNA damage and apoptosis in Ehrlich
ascites carcinoma cells. J Pharm Pharmacol. 58:263–270. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu H, Zhao X, Liu X, Xu P, Zhang K and Lin
X: Antitumor effects of traditional Chinese medicine targeting the
cellular apoptotic pathway. Drug Des Devel Ther. 9:2735–2744.
2015.PubMed/NCBI
|
